Citation Tools
PDFBasic tumor immunology
Original research
Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity